On April 27, 2023 bluebird bio, Inc. (Nasdaq: BLUE) reported that the Company’s first quarter financial results, including commercial, regulatory and operational updates, will be released pre-market on Tuesday, May 9 (Press release, bluebird bio, APR 27, 2023, View Source [SID1234630603]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

In addition, members of the management team will participate in the following upcoming investor conferences:

BofA Securities 2023 Health Care Conference, Thursday, May 11, at 8:15 a.m. PT at the Encore Hotel, Las Vegas, NV
Goldman Sachs 44th Annual Global Healthcare Conference, Monday, June 12, at 4:40 p.m. PT at the Waldorf Astoria Monarch Beach Resort & Club, Dana Point, CA
To access the live webcasts of bluebird bio’s presentations, please visit the "Events & Presentations" page within the Investors & Media section of the bluebird bio website at View Source Replays of the webcasts will be available on the bluebird bio website for 90 days following the events.